Shareholders’ Equity - Stock Option - Narrative (Details)		3 Months Ended
	Oct. 08, 2020 $ / shares shares	Mar. 31, 2025 USD ($) tranche shares	Mar. 31, 2024 USD ($) shares	Apr. 20, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, options, grants in period, gross (in shares) | shares		0	0
Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount		$ 400,000
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition		1 year 10 months 24 days
Share-based payment arrangement, nonvested award, cost not yet recognized, amount		$ 0
Performance period		5 years
Share-based payment arrangement, expense		$ 3,464,000	$ 12,977,000
Framework Agreement - Network
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of tranches | tranche		3,000
Market and service condition based options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, options, grants in period, gross (in shares) | shares		0	0
Performance shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares) | shares	4,100,000
Grants in period, weighted average grant date fair value (in usd per share) | $ / shares	$ 10.00
Options, nonvested, number of shares (in shares) | shares				3,280,000
Share-based compensation arrangement by share-based payment award, options, vested, number of shares (in shares) | shares		820,000
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value		$ 1,200,000
Restricted stock units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount		$ 56,700,000
Granted (in shares) | shares		2,935,804
Award vesting period		4 years
Equity instruments other than options, vested in period, fair value		$ 3,700,000
Total Intrinsic Value		$ 85,500,000
Weighted Average Remaining Contractual Life (Years)		2 years 8 months 12 days
Restricted stock units (RSUs) | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		1 year
Performance based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount		$ 7,900,000
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value		$ 3,800,000
Granted (in shares) | shares		1,263,273
Share-based payment arrangement, expense		$ 1,600,000	$ 1,100,000